Charles River Laboratories International Interest Expense 2011-2026 | CRL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-22.6 M	-16.5 M	95.5 M	30.5 M	73.9 M	86.4 M	60.9 M	63.8 M	29.8 M	27.7 M	15.1 M	12 M	21 M	33.3 M	42.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
95.5 M	-22.6 M	36.9 M

Quarterly Interest Expense Charles River Laboratories International

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-22.6 M	154 K	-12.2 M	-	2.59 M	-2.24 M	5.83 M	-	-6.26 M	-2.66 M	34.4 M	-	11.4 M	3.7 M	9.43 M	-	16.5 M	16.2 M	29.7 M	-	18.9 M	19.4 M	15.1 M	-	5.7 M	20.8 M	9.99 M	-	17.2 M	18.6 M	11.2 M	-	7.67 M	7.4 M	6.98 M	-	7.08 M	8.91 M	4.21 M	-	3.85 M	4.38 M	3.02 M	-	3 M	3.37 M	2.8 M	-	2.32 M	7.54 M	8.28 M	-	8.52 M	8.08 M	8.44 M	-	11.9 M	10.7 M	10 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
34.4 M	-22.6 M	7.98 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	81 M	$ 115.38	0.26 %	$ 35.1 B	USA
BioNano Genomics BNGO	5.9 M	$ 1.13	-	$ 6.15 M	USA
Burning Rock Biotech Limited BNR	1.54 M	$ 15.65	-2.86 %	$ 168 M	China
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	524 K	$ 16.19	0.87 %	$ 863 M	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	106 K	$ 1.38	0.36 %	$ 1.84 M	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
Interpace Biosciences IDXG	-252 K	$ 2.3	-	$ 10.2 M	USA
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	1 K	$ 23.22	0.39 %	$ 645 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
Medpace Holdings MEDP	-5.34 M	$ 498.0	0.91 %	$ 14.4 B	USA
Danaher Corporation DHR	-222 M	$ 189.16	-0.22 %	$ 135 B	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	-292 M	$ 121.65	0.6 %	$ 19.3 B	USA
Myriad Genetics MYGN	800 K	$ 4.37	0.34 %	$ 405 M	USA
NeoGenomics NEO	296 K	$ 7.79	1.3 %	$ 998 M	USA
Fulgent Genetics FLGT	561 K	$ 14.67	1.66 %	$ 444 M	USA
Guardant Health GH	-10.5 M	$ 79.04	0.55 %	$ 9.91 B	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	500 K	$ 2.73	1.49 %	$ 88.6 K	USA
Biomerica BMRA	367	$ 2.08	-2.8 %	$ 4.78 M	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 28.22	-0.3 %	$ 20 B	Niderland
ICON Public Limited Company ICLR	337 M	$ 107.7	0.83 %	$ 8.88 B	Irlanda
Laboratory Corporation of America Holdings LH	224 M	$ 260.87	-0.02 %	$ 21.7 B	USA
Natera NTRA	9.32 M	$ 196.81	1.96 %	$ 19.4 B	USA
Celcuity CELC	2.11 M	$ 120.91	3.22 %	$ 5.65 B	USA
Lantheus Holdings LNTH	31.3 M	$ 80.04	-0.68 %	$ 5.4 B	USA
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Senseonics Holdings SENS	-23 K	$ 6.54	-2.1 %	$ 273 M	USA
Quest Diagnostics Incorporated DGX	26 M	$ 191.24	-0.15 %	$ 21.2 B	USA
Neogen Corporation NEOG	38.1 M	$ 9.16	-2.79 %	$ 1.99 B	USA
Soleno Therapeutics SLNO	110 K	$ 52.56	-0.13 %	$ 2.67 B	USA
ENDRA Life Sciences NDRA	460 K	$ 5.0	1.21 %	$ 3.94 M	USA
Organovo Holdings ONVO	6 K	-	-2.3 %	$ 19.4 M	USA